Sentences with phrase «influenza vaccines used»

Overall the inactivated pandemic influenza vaccines used in the 2009 pandemic were effective in preventing laboratory - confirmed illness and hospitalisation.

Not exact matches

«The holy grail is to target a piece of the virus by antibody or t cell,» Tom Evans, the CEO of a company called Vaccitech that is working on a universal vaccine they hope can be used to treat all strains of influenza A, told National Geographic.

Encourage the use of inactivated influenza vaccine when feasible for children aged 6 to 23 months, as well as for their close contacts and caregivers.

In the new study, researchers at the NIAID used a virus - like particle vaccine cocktail that expressed a handful of different subtypes of a key surface protein of the influenza virus: hemagglutinin H1, H3, H5 and H7.

The BMJ also notes that three scientists who were involved in the preparation of a 2004 WHO document, WHO Guidelines on the Use of Vaccines and Antivirals during Influenza Pandemics, had received payments from pharmaceutical companies, including research funding, or consultancy or speaker fees.

Currently, most influenza vaccines in the United States are produced using chicken eggs, while a few are made in cell culture or by using recombinant DNA technologies.

Study authors said about one - in - four breakthrough cases of influenza could be prevented if the high - dose vaccine were used instead of the standard - dose vaccine.

«Vaccines are somewhat effective but can have limited use when viruses like influenza rapidly mutate from year to year.

The experimental vaccine, described in next month's Nature Biotechnology, could lead to a human influenza vaccine that uses up to 1000 times less DNA than current experimental vaccines.

Although the world's attention is focused on the novel H1N1 virus causing the swine flu pandemic, H3N2, a seasonal strain of influenza, has popped up in many East Asian countries — and some variants in circulation may outfox the seasonal vaccine in use.

Sun is currently conducting collaborative research with hydrogels for applications and efficiency with anticancer drugs screening and delivery, stem cells and wound healing, as well as being used in vaccines for H1N1 influenza and animal diseases, such as the porcine reproductive and respiratory syndrome virus, or PRRS.

«This younger population should be targeted for the use of the quadrivalent influenza vaccines.»

Kang's primary research focuses on designing and developing effective vaccines against viral diseases such as influenza virus and RSV, but he partnered with a university and research institutes in South Korea that wanted international collaborative projects to study if ginseng can be used to improve health and protect against disease because of the potential benefit in fighting these viruses.

World Health Organization (WHO) is responsible for predicting the influenza strains that will be most common during the next season and for giving recommendations on the particular virus strains that should be used for producing the vaccines for the next influenza season.

While this year's vaccine is a much better match to the circulating seasonal strains of influenza, the shifty nature of the virus and the need to pick the viruses used to make global vaccine stocks well before the onset of the flu season can make vaccine strain selection a shot in the dark.

Nearly 80 million people in 77 countries received the influenza vaccine with WHO's help — including providing a «seed» strain of the virus used by manufacturers — but the report says that «numerous systemic difficulties» slowed distribution to low - resource countries.

Our team proposes using the strains containing all the identified evolutionary markers as vaccine candidates for upcoming influenza seasons,» Kainov continues.

Molecular biologists at Philadelphia's INB: Biotechnologies are using the vegetable to make vaccines against anthrax, influenza, even plague.

Initially, all of the makers of inactivated vaccine had trouble with the «potency assay» used to ensure that 15 micrograms of influenza antigens are present in each dose.

(Two U.S. influenza vaccines do not use egg - adapted strains.

«Influenza vaccines have been in use for over 50 years, but there are very few studies that have been able to follow the same people for a long period of time particularly in such a well documented group of vaccinees.»

Influenza remains a major health problem in the United States, resulting each year in an estimated 36,000 deaths and 200,000 hospitalizations.4 Those who have been shown to be at high risk for the complications of influenza infection are children 6 to 23 months of age; healthy persons 65 years of age or older; adults and children with chronic diseases, including asthma, heart and lung disease, and diabetes; residents of nursing homes and other long - term care facilities; and pregnant women.4 It is for this reason that the Centers for Disease Control and Prevention (CDC) has recommended that these groups, together with health care workers and others with direct patient - care responsibilities, should be given priority for influenza vaccination this season in the face of the current shortage.1 Other high - priority groups include children and teenagers 6 months to 18 years of age whose underlying medical condition requires the daily use of aspirin and household members and out - of - home caregivers of infants less than 6 months old.1 Hence, in the case of vaccine shortages resulting either from the unanticipated loss of expected supplies or from the emergence of greater - than - expected global influenza activity — such as pandemic influenza, which would prompt a greater demand for vaccination5 — the capability of extending existing vaccine supplies by using alternative routes of vaccination that would require smaller doses could have important public health implInfluenza remains a major health problem in the United States, resulting each year in an estimated 36,000 deaths and 200,000 hospitalizations.4 Those who have been shown to be at high risk for the complications of influenza infection are children 6 to 23 months of age; healthy persons 65 years of age or older; adults and children with chronic diseases, including asthma, heart and lung disease, and diabetes; residents of nursing homes and other long - term care facilities; and pregnant women.4 It is for this reason that the Centers for Disease Control and Prevention (CDC) has recommended that these groups, together with health care workers and others with direct patient - care responsibilities, should be given priority for influenza vaccination this season in the face of the current shortage.1 Other high - priority groups include children and teenagers 6 months to 18 years of age whose underlying medical condition requires the daily use of aspirin and household members and out - of - home caregivers of infants less than 6 months old.1 Hence, in the case of vaccine shortages resulting either from the unanticipated loss of expected supplies or from the emergence of greater - than - expected global influenza activity — such as pandemic influenza, which would prompt a greater demand for vaccination5 — the capability of extending existing vaccine supplies by using alternative routes of vaccination that would require smaller doses could have important public health implinfluenza infection are children 6 to 23 months of age; healthy persons 65 years of age or older; adults and children with chronic diseases, including asthma, heart and lung disease, and diabetes; residents of nursing homes and other long - term care facilities; and pregnant women.4 It is for this reason that the Centers for Disease Control and Prevention (CDC) has recommended that these groups, together with health care workers and others with direct patient - care responsibilities, should be given priority for influenza vaccination this season in the face of the current shortage.1 Other high - priority groups include children and teenagers 6 months to 18 years of age whose underlying medical condition requires the daily use of aspirin and household members and out - of - home caregivers of infants less than 6 months old.1 Hence, in the case of vaccine shortages resulting either from the unanticipated loss of expected supplies or from the emergence of greater - than - expected global influenza activity — such as pandemic influenza, which would prompt a greater demand for vaccination5 — the capability of extending existing vaccine supplies by using alternative routes of vaccination that would require smaller doses could have important public health implinfluenza vaccination this season in the face of the current shortage.1 Other high - priority groups include children and teenagers 6 months to 18 years of age whose underlying medical condition requires the daily use of aspirin and household members and out - of - home caregivers of infants less than 6 months old.1 Hence, in the case of vaccine shortages resulting either from the unanticipated loss of expected supplies or from the emergence of greater - than - expected global influenza activity — such as pandemic influenza, which would prompt a greater demand for vaccination5 — the capability of extending existing vaccine supplies by using alternative routes of vaccination that would require smaller doses could have important public health implinfluenza activity — such as pandemic influenza, which would prompt a greater demand for vaccination5 — the capability of extending existing vaccine supplies by using alternative routes of vaccination that would require smaller doses could have important public health implinfluenza, which would prompt a greater demand for vaccination5 — the capability of extending existing vaccine supplies by using alternative routes of vaccination that would require smaller doses could have important public health implications.

The current epizootic in the Far East caused by avian influenza virus A (H5N1) has led to real concern about the possibility of a new pandemic of influenza.12 Technological innovation, such as the use of new vaccines delivered by the intradermal route, offers great promise to change and improve on current immunization strategies.

For influenza we offer the ferret model, the «gold standard» for infections with human influenza viruses, which will be used to assess the efficacy of vaccine candidates.

We carry out translational research programmes to develop infectious disease vaccines, therapeutics and diagnostics using animal models of tuberculosis, influenza, HIV / AIDS, Clostridium difficile, meningococcal disease, chlamydia, burkholderia and anthrax, as well as emerging viral diseases such as Crimean Congo haemorrhagic fever.

A trivalent inactivated seasonal influenza vaccine (TIV) used in humans will be compared directly in mice, ferrets and pigs.

Comparative effects of adjuvants (IRTA, SSI, HZI): The TIV influenza vaccine will be used to compare adjuvants in different species (mice, ferrets and pigs).

«The flu vaccines that we use now work by raising immunity to a part of the influenza virus called haemagglutinin, which is shortened to HA.

«The study by Egli et al. holds promise for enhancing the response of the seasonal influenza vaccine by blocking the receptor used for the innate immunity signalling molecule IL28B.

The project aims to develop an influenza vaccine that educates the immune system to recognise cross-reactive epitopes by diluting out the strain specific epitope (Epitope Dilution Phenomenon), using a combination of influenza hemagglutinin antigens delivered on virus - like particle.

His ongoing research projects include programs to develop adjuvants for use with H5N1 pandemic influenza antigens as well as West Nile Virus vaccines.

Her research involves preclinical immunology and efficacy of vaccines against H5N1 pandemic influenza, malaria, and Mycobacterium tuberculosis using mouse, ferret and guinea pig models.

«This is an interesting theoretical paper using mathematical modelling to predict the possible effects of influenza vaccines that have not yet been developed on the circulation and evolution of flu viruses.

One of the pandemic influenza projects Susan focuses on is development of an effective virus like particle (VLP) vaccine given intradermally, using microneedle technology.

Influenza vaccination rates in children may have decreased for the 2016 - 2017 influenza season because of a recommendation by the Centers for Disease Control and Prevention (CDC) that the nasal spray version of the vaccine not be used, according to Penn State College of Medicine resInfluenza vaccination rates in children may have decreased for the 2016 - 2017 influenza season because of a recommendation by the Centers for Disease Control and Prevention (CDC) that the nasal spray version of the vaccine not be used, according to Penn State College of Medicine resinfluenza season because of a recommendation by the Centers for Disease Control and Prevention (CDC) that the nasal spray version of the vaccine not be used, according to Penn State College of Medicine researchers.

«This theoretical paper by Subramanian and others uses a mathematical model to predict the effect of future influenza vaccination, using either a strain - specific or cross-reactive (or «universal») vaccine, which currently does not exist.

The U.S. Centers for Disease Control is recommending a new immunization schedule for two vaccines that recently have been licensed for use in preventing mophilus influenza type b in infants and young children.

Optimal use of vaccines for control of influenza A virus in swine.

Allen D. Leman Swine Conf 2011; 27 - 32 4 Donovan, T. Influenza isolate selection methodology for timely autogenous vaccine use, in Proceedings.

There are canine influenza vaccines available for use in dogs only.

According to the American Veterinary Medical Association, «Currently, there is no USDA - licensed vaccine against H5N1 highly pathogenic avian influenza infection available for use in companion animals in the United States.»

Pet Paradise is currently not requiring that dogs receive the canine influenza vaccine in order to use our facilities.

So with the unregulated and unpoliced use of genetic engineering, the making of a bird flu vaccine in Mexico hooking up a H5N1 influenza with the rabies virus, this chimera is now at large.

Crawford, along with colleagues at UF, Cornell University and the US Centers for Disease Control and Prevention (CDC), share intellectual rights to the canine influenza virus; Merck has licensed the right to use the virus to make a vaccine.

Interestingly, Crawford, along with colleagues at UF, Cornell University and the U.S. Centers for Disease Control and Prevention (CDC), share intellectual rights to the canine influenza virus; Merck has licensed the right to use the virus to make a vaccine.

We do have H3N2 influenza vaccine for use in high risk dogs who frequent shelters, boarding facilities, dog parks, or dog shows.

Learn how to recognize canine flu symptoms, available treatment options, and if you should use the canine influenza vaccine including potential side effects.

The facility said a vaccine for the influenza is «on the market» but has not been widely used because of «the low risk of canine influenza.»

Unlike current flu vaccines, Flublok does not use the influenza virus or eggs in its production.

As it does with all influenza vaccines, the FDA will evaluate Flublok annually prior to use by the public each flu season.